Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia

• Asıl Yazarlar: Bain, Earle E (Yazar), Shafner, Laura (Yazar), Walling, David P (Yazar), Othman, Ahmed A (Yazar), Chuang-Stein, Christy (Yazar), Hinkle, John (Yazar), Hanina, Adam (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: JMIR Publications, 2017-02-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

BackgroundAccurately monitoring and collecting drug adherence data can allow for better understanding and interpretation of the outcomes of clinical trials. Most clinical trials use a combination of pill counts and self-reported data to measure drug adherence, despite the drawbacks of relying on the...